[Chemoresistance of Mycobacterium tuberculosis; general aspects and relation to clinical manifestations and therapy; immunity and allergy in antibacterial-treated tuberculosis].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents; D006967:Hypersensitivity; D007154:Immune System Diseases; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000628:therapy*
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D013307:Streptomycin
MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS/therapy
La chemioresistenza del micobatterio tubercolare in alcuni suoi aspetti generali e nei suoi rapporti con la clinica e la terapia; immunità e allergia nella tubercolosi trattata con antibatterici.